ICorNet Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$1.6M
- Investors
-
13
ICorNet General Information
Description
Developer of a tailor-made cardiac support net designed to treat patients with severe heart failure. The company offers a heart support net that is a mesh bag to prevent progressive heart enlargement, designed and manufactured in a tailor-made manner to optimize cardiac function based on a three-dimensional heart model for each patient created from MRI and CT images, enabling patients to undergo surgery completed in a limited time with a minimum burden.
Contact Information
Website
www.icornet.jpCorporate Office
- Nagoya Medical Engineering Collaboration Incubator 203
- 2-22-8 Chikusa, Chikusa-ku
- Nagoya, Aichi 464-0858
- Japan
Corporate Office
- Nagoya Medical Engineering Collaboration Incubator 203
- 2-22-8 Chikusa, Chikusa-ku
- Nagoya, Aichi 464-0858
- Japan
ICorNet Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series C) | 10-Feb-2026 | $1.6M | Completed | Clinical Trials - Phase 2 | ||
| 7. Accelerator/Incubator | 09-Nov-2022 | Completed | Clinical Trials - Phase 2 | |||
| 6. Accelerator/Incubator | Completed | Clinical Trials - Phase 2 | ||||
| 5. Later Stage VC | 29-Mar-2021 | Completed | Clinical Trials - Phase 2 | |||
| 4. Accelerator/Incubator | 01-Jan-2021 | Completed | Clinical Trials - Phase 2 | |||
| 3. Accelerator/Incubator | 01-Jan-2021 | Completed | Clinical Trials - Phase 2 | |||
| 2. Early Stage VC (Series A) | 05-Feb-2018 | $2.64M | $2.64M | Completed | Clinical Trials - Phase 2 | |
| 1. Accelerator/Incubator | Completed | Startup |
ICorNet Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred B | ||||||||
| Preferred A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
ICorNet Patents
ICorNet Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024218881-A1 | Energization device for organ | Inactive | 19-Apr-2023 | ||
| JP-7463002-B2 | Cardiac net installation device and installation method | Active | 21-Feb-2022 | ||
| EP-4483842-A1 | Heart net placement tool and placement method | Pending | 21-Feb-2022 | ||
| EP-4483842-A4 | Heart net placement tool and placement method | Pending | 21-Feb-2022 | ||
| WO-2023157272-A1 | Heart net placement tool and placement method | Inactive | 21-Feb-2022 | A61N1/0597 |
ICorNet Signals
ICorNet Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Diamond Medino Capital | Venture Capital | Minority | ||
| TRKS | Corporation | Minority | ||
| Central Japan Startup Ecosystem | Accelerator/Incubator | |||
| Kondo Research Institute | Corporation | Minority | ||
| Plug and Play | Accelerator/Incubator | Minority |
ICorNet FAQs
-
When was ICorNet founded?
ICorNet was founded in 2016.
-
Where is ICorNet headquartered?
ICorNet is headquartered in Nagoya, Japan.
-
What is the size of ICorNet?
ICorNet has 7 total employees.
-
What industry is ICorNet in?
ICorNet’s primary industry is Therapeutic Devices.
-
Is ICorNet a private or public company?
ICorNet is a Private company.
-
What is ICorNet’s current revenue?
The current revenue for ICorNet is .
-
How much funding has ICorNet raised over time?
ICorNet has raised $6.64M.
-
Who are ICorNet’s investors?
Diamond Medino Capital, TRKS, Central Japan Startup Ecosystem, Kondo Research Institute, and Plug and Play are 5 of 13 investors who have invested in ICorNet.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process